Mike Hubank
@generoom.bsky.social
530 followers
450 following
150 posts
Clinical Genomics in the UK.
Scientific Director of Clinical Genomics at the Royal Marsden and North Thames GLH. Prof of Translational Genomics at ICR, London
Posts
Media
Videos
Starter Packs
Reposted by Mike Hubank
Reposted by Mike Hubank
BRCA gene testing can identify cancer risk, but access is limited.
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
A new digital pathway from the ICR is expanding testing in high-risk groups by making the process more efficient and cost-effective.
In the longer term, this approach could lead to better patient outcomes.
More from us here ⬇️
Could expanding BRCA gene testing save lives in breast and ovarian cancer?
Could expanding BRCA gene testing save lives in breast and ovarian cancer?
www.icr.ac.uk
Reposted by Mike Hubank
Reposted by Mike Hubank
www.bbc.com/news/article...
Harpal Kumar said the results were very compelling. That's because he is a businessman with a huge financial conflict of interest and a poor understanding of the science required to determine whether a screening test is useful.
Harpal Kumar said the results were very compelling. That's because he is a businessman with a huge financial conflict of interest and a poor understanding of the science required to determine whether a screening test is useful.
Galleri test: Exciting results from blood test for 50 cancers
The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.
www.bbc.com
Reposted by Mike Hubank
Reposted by Mike Hubank
Reposted by Mike Hubank
Reposted by Mike Hubank
Reposted by Mike Hubank
Our latest work is out in Nature today. In this paper, we introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 errors per billion bp in single DNA molecules, and use it to study the somatic mutation landscape of oral epithelium in >1000 people www.nature.com/articles/s41...
Somatic mutation and selection at population scale - Nature
A new version of nanorate DNA sequencing, with an error rate lower than five errors per billion base pairs and compatible with whole-exome and targeted capture, enables epidemiological-scale studies of somatic mutation and selection and the generation of high-resolution selection maps across coding and non-coding sites for many genes.
www.nature.com
Reposted by Mike Hubank
Mike Hubank
@generoom.bsky.social
· Sep 30
Mike Hubank
@generoom.bsky.social
· Sep 30
🧬💥 Do the genetics that make you develop a disease also help you survive it? Not much.
Our new study in Nature Genetics including 9 disease and 7 biobanks shows:
• Susceptibility variants ≠ survival
• PRSs for onset weak at predicting progression
• Lifespan PRS predicts survival better
Our new study in Nature Genetics including 9 disease and 7 biobanks shows:
• Susceptibility variants ≠ survival
• PRSs for onset weak at predicting progression
• Lifespan PRS predicts survival better
Mike Hubank
@generoom.bsky.social
· Sep 29
Energy Dashboard - real time and historical GB National Grid electricity data, carbon emissions and UK generation sites mapping
Real-time half-hourly data on UK electricity generation, renewable vs fossil fuel mix, power flow visualisation and carbon intensity from National Grid.
www.energydashboard.co.uk
Mike Hubank
@generoom.bsky.social
· Sep 27